Toll Free: 1-888-928-9744

Global Urological Cancer Drugs Market Size, Status and Forecast 2018-2025

Published: Aug, 2018 | Pages: 102 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report focuses on the global Urological Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urological Cancer Drugs development in United States, Europe and China.

In 2017, the global Urological Cancer Drugs market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.

The key players covered in this study
    Novartis
    Pfizer
    Johnson & Johnson
    AstraZeneca
    Astellas
    Bristol-Myers Squibb
    Abbott Laboratories
    Celgene Corporation
    Dendreon Corporation
    Ferring Pharmaceuticals
    GlaxoSmithKline
    Indevus Pharmaceuticals Inc
    Ipsen
    Roche Healthcare
    Sanofi S.A
    Tolmar Inc

Market segment by Type, the product can be split into
    Tablets
    Injection

Market segment by Application, split into
    Prostate Cancer
    Bladder Cancer
    Kidney Cancer
    Testicular Cancer
    Other

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Urological Cancer Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Urological Cancer Drugs development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Urological Cancer Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Urological Cancer Drugs Market Size Growth Rate by Type (2013-2025)
        1.4.2 Tablets
        1.4.3 Injection
    1.5 Market by Application
        1.5.1 Global Urological Cancer Drugs Market Share by Application (2013-2025)
        1.5.2 Prostate Cancer
        1.5.3 Bladder Cancer
        1.5.4 Kidney Cancer
        1.5.5 Testicular Cancer
        1.5.6 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Urological Cancer Drugs Market Size
    2.2 Urological Cancer Drugs Growth Trends by Regions
        2.2.1 Urological Cancer Drugs Market Size by Regions (2013-2025)
        2.2.2 Urological Cancer Drugs Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Urological Cancer Drugs Market Size by Manufacturers
        3.1.1 Global Urological Cancer Drugs Revenue by Manufacturers (2013-2018)
        3.1.2 Global Urological Cancer Drugs Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Urological Cancer Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Urological Cancer Drugs Key Players Head office and Area Served
    3.3 Key Players Urological Cancer Drugs Product/Solution/Service
    3.4 Date of Enter into Urological Cancer Drugs Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Urological Cancer Drugs Market Size by Type (2013-2018)
    4.2 Global Urological Cancer Drugs Market Size by Application (2013-2018)

5 United States
    5.1 United States Urological Cancer Drugs Market Size (2013-2018)
    5.2 Urological Cancer Drugs Key Players in United States
    5.3 United States Urological Cancer Drugs Market Size by Type
    5.4 United States Urological Cancer Drugs Market Size by Application

6 Europe
    6.1 Europe Urological Cancer Drugs Market Size (2013-2018)
    6.2 Urological Cancer Drugs Key Players in Europe
    6.3 Europe Urological Cancer Drugs Market Size by Type
    6.4 Europe Urological Cancer Drugs Market Size by Application

7 China
    7.1 China Urological Cancer Drugs Market Size (2013-2018)
    7.2 Urological Cancer Drugs Key Players in China
    7.3 China Urological Cancer Drugs Market Size by Type
    7.4 China Urological Cancer Drugs Market Size by Application

8 Japan
    8.1 Japan Urological Cancer Drugs Market Size (2013-2018)
    8.2 Urological Cancer Drugs Key Players in Japan
    8.3 Japan Urological Cancer Drugs Market Size by Type
    8.4 Japan Urological Cancer Drugs Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Urological Cancer Drugs Market Size (2013-2018)
    9.2 Urological Cancer Drugs Key Players in Southeast Asia
    9.3 Southeast Asia Urological Cancer Drugs Market Size by Type
    9.4 Southeast Asia Urological Cancer Drugs Market Size by Application

10 India
    10.1 India Urological Cancer Drugs Market Size (2013-2018)
    10.2 Urological Cancer Drugs Key Players in India
    10.3 India Urological Cancer Drugs Market Size by Type
    10.4 India Urological Cancer Drugs Market Size by Application

11 Central & South America
    11.1 Central & South America Urological Cancer Drugs Market Size (2013-2018)
    11.2 Urological Cancer Drugs Key Players in Central & South America
    11.3 Central & South America Urological Cancer Drugs Market Size by Type
    11.4 Central & South America Urological Cancer Drugs Market Size by Application

12 International Players Profiles
    12.1 Novartis
        12.1.1 Novartis Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Urological Cancer Drugs Introduction
        12.1.4 Novartis Revenue in Urological Cancer Drugs Business (2013-2018)
        12.1.5 Novartis Recent Development
    12.2 Pfizer
        12.2.1 Pfizer Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Urological Cancer Drugs Introduction
        12.2.4 Pfizer Revenue in Urological Cancer Drugs Business (2013-2018)
        12.2.5 Pfizer Recent Development
    12.3 Johnson & Johnson
        12.3.1 Johnson & Johnson Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Urological Cancer Drugs Introduction
        12.3.4 Johnson & Johnson Revenue in Urological Cancer Drugs Business (2013-2018)
        12.3.5 Johnson & Johnson Recent Development
    12.4 AstraZeneca
        12.4.1 AstraZeneca Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Urological Cancer Drugs Introduction
        12.4.4 AstraZeneca Revenue in Urological Cancer Drugs Business (2013-2018)
        12.4.5 AstraZeneca Recent Development
    12.5 Astellas
        12.5.1 Astellas Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Urological Cancer Drugs Introduction
        12.5.4 Astellas Revenue in Urological Cancer Drugs Business (2013-2018)
        12.5.5 Astellas Recent Development
    12.6 Bristol-Myers Squibb
        12.6.1 Bristol-Myers Squibb Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Urological Cancer Drugs Introduction
        12.6.4 Bristol-Myers Squibb Revenue in Urological Cancer Drugs Business (2013-2018)
        12.6.5 Bristol-Myers Squibb Recent Development
    12.7 Abbott Laboratories
        12.7.1 Abbott Laboratories Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Urological Cancer Drugs Introduction
        12.7.4 Abbott Laboratories Revenue in Urological Cancer Drugs Business (2013-2018)
        12.7.5 Abbott Laboratories Recent Development
    12.8 Celgene Corporation
        12.8.1 Celgene Corporation Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Urological Cancer Drugs Introduction
        12.8.4 Celgene Corporation Revenue in Urological Cancer Drugs Business (2013-2018)
        12.8.5 Celgene Corporation Recent Development
    12.9 Dendreon Corporation
        12.9.1 Dendreon Corporation Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Urological Cancer Drugs Introduction
        12.9.4 Dendreon Corporation Revenue in Urological Cancer Drugs Business (2013-2018)
        12.9.5 Dendreon Corporation Recent Development
    12.10 Ferring Pharmaceuticals
        12.10.1 Ferring Pharmaceuticals Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Urological Cancer Drugs Introduction
        12.10.4 Ferring Pharmaceuticals Revenue in Urological Cancer Drugs Business (2013-2018)
        12.10.5 Ferring Pharmaceuticals Recent Development
    12.11 GlaxoSmithKline
    12.12 Indevus Pharmaceuticals Inc
    12.13 Ipsen
    12.14 Roche Healthcare
    12.15 Sanofi S.A
    12.16 Tolmar Inc

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
List of Tables and Figures

    Table Urological Cancer Drugs Key Market Segments
    Table Key Players Urological Cancer Drugs Covered
    Table Global Urological Cancer Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Urological Cancer Drugs Market Size Market Share by Type 2013-2025
    Figure Tablets Figures
    Table Key Players of Tablets
    Figure Injection Figures
    Table Key Players of Injection
    Table Global Urological Cancer Drugs Market Size Growth by Application 2013-2025 (Million US$)
    Figure Prostate Cancer Case Studies
    Figure Bladder Cancer Case Studies
    Figure Kidney Cancer Case Studies
    Figure Testicular Cancer Case Studies
    Figure Other Case Studies
    Figure Urological Cancer Drugs Report Years Considered
    Table Global Urological Cancer Drugs Market Size 2013-2025 (Million US$)
    Figure Global Urological Cancer Drugs Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Urological Cancer Drugs Market Size by Regions 2013-2025 (Million US$)
    Table Global Urological Cancer Drugs Market Size by Regions 2013-2018 (Million US$)
    Table Global Urological Cancer Drugs Market Share by Regions 2013-2018
    Figure Global Urological Cancer Drugs Market Share by Regions 2013-2018
    Figure Global Urological Cancer Drugs Market Share by Regions 2018
    Table Market Top Trends
    Table Global Urological Cancer Drugs Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Urological Cancer Drugs Market Share by Manufacturers (2013-2018)
    Figure Global Urological Cancer Drugs Market Share by Manufacturers in 2018
    Table Global Urological Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Urological Cancer Drugs Product/Solution/Service
    Table Date of Enter into Urological Cancer Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table Global Urological Cancer Drugs Market Size Share by Type (2013-2018)
    Figure Global Urological Cancer Drugs Market Size Market Share by Type (2013-2018)
    Table Global Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table Global Urological Cancer Drugs Market Size Share by Application (2013-2018)
    Figure Global Urological Cancer Drugs Market Size Market Share by Application (2013-2018)
    Figure Global Urological Cancer Drugs Revenue Market Share by Application in 2017
    Figure United States Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table United States Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table United States Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table United States Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table United States Urological Cancer Drugs Market Share by Type (2013-2018)
    Table United States Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table United States Urological Cancer Drugs Market Share by Application (2013-2018)
    Figure Europe Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table Europe Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table Europe Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table Europe Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table Europe Urological Cancer Drugs Market Share by Type (2013-2018)
    Table Europe Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table Europe Urological Cancer Drugs Market Share by Application (2013-2018)
    Figure China Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table China Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table China Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table China Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table China Urological Cancer Drugs Market Share by Type (2013-2018)
    Table China Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table China Urological Cancer Drugs Market Share by Application (2013-2018)
    Figure Japan Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table Japan Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table Japan Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table Japan Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table Japan Urological Cancer Drugs Market Share by Type (2013-2018)
    Table Japan Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table Japan Urological Cancer Drugs Market Share by Application (2013-2018)
    Figure Southeast Asia Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table Southeast Asia Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Urological Cancer Drugs Market Share by Type (2013-2018)
    Table Southeast Asia Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Urological Cancer Drugs Market Share by Application (2013-2018)
    Figure India Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table India Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table India Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table India Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table India Urological Cancer Drugs Market Share by Type (2013-2018)
    Table India Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table India Urological Cancer Drugs Market Share by Application (2013-2018)
    Figure Central & South America Urological Cancer Drugs Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Urological Cancer Drugs Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Urological Cancer Drugs Market Share (2017-2018)
    Table Central & South America Urological Cancer Drugs Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Urological Cancer Drugs Market Share by Type (2013-2018)
    Table Central & South America Urological Cancer Drugs Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Urological Cancer Drugs Market Share by Application (2013-2018)
    Table Novartis Company Details
    Table Novartis Revenue in Urological Cancer Drugs Business (2013-2018) (Million US$)
    Figure Novartis Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Novartis Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Pfizer Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Pfizer Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Johnson & Johnson Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure AstraZeneca Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table AstraZeneca Recent Development
    Table Astellas Company Details
    Table Astellas Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Astellas Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Astellas Recent Development
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Bristol-Myers Squibb Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Bristol-Myers Squibb Recent Development
    Table Abbott Laboratories Company Details
    Table Abbott Laboratories Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Abbott Laboratories Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Abbott Laboratories Recent Development
    Table Celgene Corporation Company Details
    Table Celgene Corporation Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Celgene Corporation Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Celgene Corporation Recent Development
    Table Dendreon Corporation Company Details
    Table Dendreon Corporation Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Dendreon Corporation Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Dendreon Corporation Recent Development
    Table Ferring Pharmaceuticals Company Details
    Table Ferring Pharmaceuticals Revenue in Urological Cancer Drugs Business (2013-2018)(Million US$)
    Figure Ferring Pharmaceuticals Revenue Growth Rate in Urological Cancer Drugs Business (2013-2018)
    Table Ferring Pharmaceuticals Recent Development
    Table GlaxoSmithKline Company Details
    Table Indevus Pharmaceuticals Inc Company Details
    Table Ipsen Company Details
    Table Roche Healthcare Company Details
    Table Sanofi S.A Company Details
    Table Tolmar Inc Company Details
    Table Global Urological Cancer Drugs Market Size by Regions (Million US$) 2018-2025
    Figure Global Urological Cancer Drugs Market Size Share by Regions (2018-2025)
    Figure Global Urological Cancer Drugs Market Size Share by Regions in 2025
    Figure United States Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure China Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure India Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Urological Cancer Drugs Market Size Forecast (2018-2025)(Million USD)
    Table Global Urological Cancer Drugs Market Size by Product (2018-2025) (Million US$)
    Figure Global Urological Cancer Drugs Market Size by Product (2018-2025)
    Figure Global Urological Cancer Drugs Market Size by Product in 2025
    Table Global Urological Cancer Drugs Market Size by Application (2018-2025) (Million US$)
    Figure Global Urological Cancer Drugs Market Size by Application (2018-2025)
    Figure Global Urological Cancer Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3900
Multi User - US $7800
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify